The involvement of MACC1 and ALDH1 in the recurrence and metastasis of NSCLC suggest that they could be valuable biomarkers for measuring disease progression and developing more accurate therapeutic strategies. The gene discussed is MACC1; the disease is non-small cell lung carcinoma.